Genomics in Newborn Screening - 18/12/13
Doi : 10.1016/j.jpeds.2013.07.028
Yuval E. Landau, MD, PhD 1, 3, Uta Lichter-Konecki, MD, PhD 2, Harvey L. Levy, MD 1, ⁎ 
1 Division of Genetics, Boston Children's Hospital and the Department of Pediatrics, Harvard Medical School, Boston, MA
2 Division of Genetics and Metabolism, Children's National Medical Center and the Department of Pediatrics, The George Washington University School of Medicine, Washington, DC
3 Pediatric Neurology Unit, Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel
∗Reprint requests: Harvey L. Levy, MD, Boston Children's Hospital, One Autumn St, Room 526.1, Boston, MA 02115.
Keyword : ACMG, NGS, PCR, PKU, VLCAD, VUS, WES, WGS
Plan
| U.L.-K. and H.L. are partially supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (9U54HD061221). The authors declare no conflicts of interest. |
© 2014
Mosby, Inc. Tous droits réservés.
Vol 164 - N° 1
P. 14-19 - janvier 2014 Retour au numéro
Article précédent
- Long-Term Respiratory Morbidities after Bronchopulmonary Dysplasia despite Current Therapies
- Waldemar A. Carlo
- Prevalence and Neonatal Factors Associated with Autism Spectrum Disorders in Preterm Infants
- Michael W. Kuzniewicz, Soora Wi, Yinge Qian, Eileen M. Walsh, Mary Anne Armstrong, Lisa A. Croen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?